Literature DB >> 16425426

Effects of Helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia: a 3-year follow-up study.

Bin Lu1, Ming-Tao Chen, Yi-Hong Fan, Yan Liu, Li-Na Meng.   

Abstract

AIM: To investigate the effect of H pylori eradication on atrophic gastritis and intestinal metaplasia (IM).
METHODS: Two hundred and fifty-nine patients with atrophic gastritis in the antrum were included in the study, 154 patients were selected for H pylori eradication therapy and the remaining 105 patients served as untreated group. Gastroscopy and biopsies were performed both at the beginning and at the end of a 3-year follow-up study. Gastritis was graded according to the updated Sydney system.
RESULTS: One hundred and seventy-nine patients completed the follow-up, 92 of them received H pylori eradication therapy and the remaining 87 H pylori-infected patients were in the untreated group. Chronic gastritis, active gastritis and the grade of atrophy significantly decreased in H pylori eradication group (P<0.01). However, the grade of IM increased in H pylori -infected group (P<0.05).
CONCLUSION: H pylori eradication may improve gastric mucosal inflammation, atrophy and prevent the progression of IM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16425426      PMCID: PMC4355796          DOI: 10.3748/wjg.v11.i41.6518

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  11 in total

1.  Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia.

Authors:  M F Dixon
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

2.  Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study.

Authors:  R W van der Hulst; A van der Ende; F W Dekker; F J Ten Kate; J F Weel; J J Keller; S P Kruizinga; J Dankert; G N Tytgat
Journal:  Gastroenterology       Date:  1997-07       Impact factor: 22.682

3.  Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated.

Authors:  T Ohkusa; K Fujiki; I Takashimizu; J Kumagai; T Tanizawa; Y Eishi; T Yokoyama; M Watanabe
Journal:  Ann Intern Med       Date:  2001-03-06       Impact factor: 25.391

4.  Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.

Authors:  P Correa; E T Fontham; J C Bravo; L E Bravo; B Ruiz; G Zarama; J L Realpe; G T Malcom; D Li; W D Johnson; R Mera
Journal:  J Natl Cancer Inst       Date:  2000-12-06       Impact factor: 13.506

5.  Effect of Helicobacter pylori infection on gastric epithelial proliferation in progression from normal mucosa to gastriccarcinoma.

Authors:  Wen-Zhong Liu; Xiong Zheng; Yao Shi; Quan-Jiang Dong; Shu-Dong Xiao
Journal:  World J Gastroenterol       Date:  1998-06       Impact factor: 5.742

6.  Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study.

Authors:  J J Sung; S R Lin; J Y Ching; L Y Zhou; K F To; R T Wang; W K Leung; E K Ng; J Y Lau; Y T Lee; C K Yeung; W Chao; S C Chung
Journal:  Gastroenterology       Date:  2000-07       Impact factor: 22.682

7.  The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia.

Authors:  A Kokkola; P Sipponen; H Rautelin; M Härkönen; T U Kosunen; R Haapiainen; P Puolakkainen
Journal:  Aliment Pharmacol Ther       Date:  2002-03       Impact factor: 8.171

Review 8.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.

Authors:  M F Dixon; R M Genta; J H Yardley; P Correa
Journal:  Am J Surg Pathol       Date:  1996-10       Impact factor: 6.394

9.  Long-term follow-up of gastric histology after Helicobacter pylori eradication.

Authors:  G M Forbes; J R Warren; M E Glaser; D J Cullen; B J Marshall; B J Collins
Journal:  J Gastroenterol Hepatol       Date:  1996-07       Impact factor: 4.029

10.  Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis.

Authors:  M Ito; K Haruma; T Kamada; M Mihara; S Kim; Y Kitadai; M Sumii; S Tanaka; M Yoshihara; K Chayama
Journal:  Aliment Pharmacol Ther       Date:  2002-08       Impact factor: 8.171

View more
  13 in total

1.  IL-11 is a parietal cell cytokine that induces atrophic gastritis.

Authors:  Meegan Howlett; Heather V Chalinor; Jon N Buzzelli; Nhung Nguyen; Ian R van Driel; Katrina M Bell; James G Fox; Eva Dimitriadis; Trevelyan R Menheniott; Andrew S Giraud; Louise M Judd
Journal:  Gut       Date:  2011-12-16       Impact factor: 23.059

2.  Screening test for anti-Helicobacter pylori activity of traditional Chinese herbal medicines.

Authors:  Feng Ma; Ye Chen; Jing Li; He-Ping Qing; Ji-De Wang; Ya-Li Zhang; Bei-Guo Long; Yang Bai
Journal:  World J Gastroenterol       Date:  2010-11-28       Impact factor: 5.742

3.  Genetic association of interleukin-1 haplotypes with gastritis and precancerous lesions in North Indians.

Authors:  B R Achyut; N Moorchung; B Mittal
Journal:  Clin Exp Med       Date:  2008-04-03       Impact factor: 3.984

4.  Chronic tamoxifen use is associated with a decreased risk of intestinal metaplasia in human gastric epithelium.

Authors:  Chang Mo Moon; Seok-Hyung Kim; Sang Kil Lee; Jiyeon Hyeon; Ja Seung Koo; Sangheun Lee; Jean S Wang; Won Jae Huh; Shradha S Khurana; Jason C Mills
Journal:  Dig Dis Sci       Date:  2013-12-25       Impact factor: 3.199

5.  Reinfection rate and endoscopic changes after successful eradication of Helicobacter pylori.

Authors:  Kum Hei Ryu; Sun Young Yi; Youn Ju Na; Su Jung Baik; Su Jin Yoon; Hae-Sun Jung; Hyun Joo Song
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

Review 6.  Helicobacter pylori eradication for preventing gastric cancer.

Authors:  Bin Lu; Meng Li
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

Review 7.  Histological changes of gastric mucosa after Helicobacter pylori eradication: a systematic review and meta-analysis.

Authors:  Yan-Jun Kong; Hong-Gang Yi; Jun-Cheng Dai; Mu-Xin Wei
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

Review 8.  Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer.

Authors:  Yo Han Park; Nayoung Kim
Journal:  J Cancer Prev       Date:  2015-03

9.  AGA Technical Review on Gastric Intestinal Metaplasia-Natural History and Clinical Outcomes.

Authors:  Andrew J Gawron; Shailja C Shah; Osama Altayar; Perica Davitkov; Douglas Morgan; Kevin Turner; Reem A Mustafa
Journal:  Gastroenterology       Date:  2019-12-06       Impact factor: 22.682

10.  Clinical background factors affecting outcomes of Helicobacter pylori eradication therapy in primary care.

Authors:  Nozomi Yokota; Ryusuke Ae; Masaki Amenomori; Koji Kitagawa; Takuya Nakamura; Tetsuro Yokota; Kato Masato; Teppei Sasahara; Yuri Matsubara; Koki Kosami; Yoshikazu Nakamura
Journal:  J Gen Fam Med       Date:  2019-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.